M. Gutierrez
All authors
About
Publications While At HealthPartners
selected publications
Abstract
Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with Pembrolizumab: clinical update [abstract]
.
Journal of Clinical Oncology.
2024
Contact
full name
M.
Gutierrez
Quick Info
Collaboration
Co-author network
Map of science
